<DOC>
	<DOCNO>NCT00204386</DOCNO>
	<brief_summary>The purpose study determine Topiramate safe effective use civilian subject Posttraumatic Stress Disorder .</brief_summary>
	<brief_title>Safety &amp; Efficacy Study Using Topiramate Posttraumatic Stress Disorder</brief_title>
	<detailed_description>Civilian PTSD widespread psychiatric condition commonly underestimated term prevalence morbidity , least United States probably world-wide . The magnitude public health impact PTSD highlight recent epidemiologic finding . Kessler , et al , estimate 7.8 % lifetime prevalence PTSD representative national sample 5877 person age 15-54 . In part , high prevalence due high occurrence trauma exposure lifetime . Common type Civilian PTSD include serious physical attack assault , rape , sexual assault , transportation accident , exposure death/homicide serious injury , life-threatening accident , threat injury fire , flood , weapon , natural disaster civilian exposure military attack . Persons PTSD usually unaware disorder treatment professional inadequately sensitize high prevalence condition , condition markedly undiagnosed thereby undertreated . The risk PTSD restrict psychiatric population . In general , person PTSD seek help general medical mental health setting . Individuals PTSD increase risk co-morbid psychiatric disorder include depression , alcohol drug abuse , panic disorder , agoraphobia personality disorder . It associate substantially high suicide risk , hospitalization rate , increased utilization rate non-psychiatric medical service well mental health service .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Stress Disorders , Traumatic</mesh_term>
	<mesh_term>Stress Disorders , Post-Traumatic</mesh_term>
	<mesh_term>Topiramate</mesh_term>
	<criteria>PTSD define DSMIV least 6 month support Structured Clinical Interview DSMIV Axis I Disorders ( SCIDI ) ; Subjects must minimum past week CAPS score &gt; 50 Visit 2 ; Subjects must general good health confirm medical history , physical examination ; Subjects must prohibit medication washout period outline Concomitant Therapy section ; Subjects must negative urine drug screen ( phencyclidine , cocaine , amphetamine , tetrahydrocannabinol , opiate ) visit 1 ; Subjects must either postmenopausal least 1 year , hysterectomy tubal ligation , otherwise incapable pregnancy practice one follow method contraception least one month prior enrollment : hormonal contraceptive , spermicide barrier , intrauterine device , spousal/partner sterility practice abstinence agree continue abstinence use acceptable method contraception ( list ) sexual activity commence . Subjects must able take oral medication , adhere medication regiment willing return regular visit ; After full explanation study , subject must demonstrate willingness participate signing informed consent form . Subjects DSMIV diagnosis substance dependence abuse ( exception nicotine caffeine dependence ) within past 3 month ; Subjects current past history primary major depressive disorder primary major anxiety disorder ( i.e . panic disorder , obsessivecompulsive disorder , social phobia ) define DSMIV ; Subjects current lifetime history schizophrenia , bipolar disorder , psychotic disorder ; Subjects diagnosis current organic mental disorder , factitious disorder malinger Subjects diagnosis bulimia anorexia nervosa ; Subjects currently enrol cognitivebehavioral therapy ; Subjects current disability compensation claim pending persist functional impairment relate PTSD ; Subjects prior nonresponse topiramate treatment PTSD follow adequate trial . Subjects previously treat topiramate discontinue treatment due adverse event subject know hypersensitivity topiramate ; Subjects clinically unstable disease : cardiovascular , renal , gastrointestinal , pulmonary , metabolic , endocrine systemic disease could interfere participation study ; Subjects history nephrolithiasis ; Subjects SGOT and/or SGPT level great 2 time upper limit normal range screening ; Subjects take antipsychotic within 3 month screen visit ; Subjects progressive degenerative neurologic disorder ( e.g . multiple sclerosis ) ; Subjects active liver disease ; Subjects estimate creatinine clearance &lt; 60 mL/min ; Subjects know clinically significant medical condition , include limited : symptomatic coronary artery peripheral vascular disease , malignancy within past 5 year , except basal cell carcinoma ; condition compromise function body system could result altered absorption , excess accumulation impair metabolism excretion topiramate ; subject history attempt suicide/homicide past 12 month suicidal/homicidal tendency judge clinically serious suicidal/homicidal risk ; Subjects pregnant lactating ; Subjects observe designate washout period prohibit medication outline protocol ; Subjects opinion investigator enrol study Precautions , Warnings , Contraindications topiramate package insert .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>May 2007</verification_date>
	<keyword>Posttraumatic Stress Disorder</keyword>
</DOC>